Brinsupri
Active substance: brensocatib
TABLET · BRENSOCATIB 25 mg/1
United StatesActive
Marketing holder: Insmed Incorporated
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BRENSOCATIB · 25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-f57e-738e-8557-4c44d9860828,01a12099-a547-7101-9f7f-c2d7a6c7dc06;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71558-002
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 71558-002 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71558-002 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71558-002 · Verified 2026-10-09 · open in source